Top Hyperbaric Oxygen Therapy Companies

Hyperbaric Oxygen Therapy Market size was valued at USD 38.59 Billion in 2024 and is poised to grow from USD 41.14 Billion in 2025 to USD 68.59 Billion by 2033, growing at a CAGR of 6.6% during the forecast period (2026–2033).

The global Hyperbaric Oxygen Therapy market is highly competitive with the presence of several international and local players across the globe. Product diversification, advancement, merger & acquisition and quality enhancement are the leading key strategies opting through prominent market players.  'Sechrist Industries, Inc. (US) ', 'Perry Baromedical Corporation (US) ', 'Environmental Tectonics Corporation (ETC) (US) ', 'Hyperbaric FX (US) ', 'OxyHeal Health Group (Australia) ', 'HAUX-LIFE-SUPPORT GmbH (Germany) ', 'Kobotek Medical Instruments Co., Ltd. (China) ', 'CVR Medical Group, Inc. (Canada) ', 'SeoHyun Enterprise Co., Ltd. (South Korea) ', 'Fink Engineering Pty Ltd (Australia) ', 'Gulf Coast Hyperbarics (US) ', 'Hyperbaric Vermont (US) ', 'Newtowne Hyperbarics (US) ', 'CHI Health (US) ', 'Healogics (US) ', 'Baromedical Services, Inc. (US) ', 'IHC Hyberbarics, Inc. (US) ', 'SOS Medical Products (US) ', 'OxyFlow Hyperbaric (US) ', 'InSight Health Services (US)'

The rise in demand for devices for hyperbaric oxygen therapy is due to the increasing number of diabetic patients worldwide. As a result, the market will have an upward tendency over time.

Technological Advancement will Provoke Market Growth Exponentially in Coming Years: Growing adoption of wound healing, widespread availability of monoplace systems, rising demand for the convenience of handling, and reduced hospital gas supply requirements are the factors that are anticipated to accelerate the sales of monoplace HBOT devices. Monoplace HBOT devices can handle a large number of patients with various diseases and assist medical personnel in monitoring all of the patient's indications and symptoms. Increased penetration to provide portability and user-friendly operability will also help to propel the HBOT devices market forward.

Globally, North America was the leading segment and accounted for around 32% of the total revenue in 2016. The U.S. was the leading market in 2022 and is also anticipated to hold largest revenue share over the forecast period. According to the American Venous Forum, advanced venous diseases characterized by skin changes and leg ulceration affect over 2.5 million people annually in the U.S. The increasing prevalence of chronic & acute wounds and simultaneously growing treatment rate due to the presence of developed healthcare technology, growing healthcare expenditure, and huge disposable income are some of the factors that are expected to boost the market over the coming years.